Yahoo
NYSE - Delayed Quote USD

Dr. Reddy's Laboratories Limited (RDY)

14.17 +0.06 (+0.43%)
At close: October 30 at 4:00:02 PM EDT
14.17 0.00 (0.00%)
After hours: October 30 at 5:21:51 PM EDT
Trade RDY on Coinbase

News headlines

Updated 33m ago
Powered by Yahoo Scout

Dr. Reddy’s Laboratories reported fiscal second-quarter revenue of $905 millionand EPS (earnings per share) of $0.12 per ADS (American Depositary Share), both below estimates. Lower North American lenalidomide sales offset double-digit growth in several underlying businesses. The company is preparing to resume semaglutide supplies in November 2026, while biosimilar launches and a large regulatory pipeline remain key developments.

Mobilize your Website
View Site in Mobile | Classic
Share by: